跳转至内容
Merck
CN

A2691

抗人IgA (α链特异性)−琼脂糖偶联 山羊抗

affinity isolated antibody, adsorbed with mouse and rat IgG

别名:

山羊抗人IgA

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.46
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

抗人IgA (α链特异性)−琼脂糖偶联 山羊抗, affinity isolated antibody, adsorbed with mouse and rat IgG

biological source

goat

conjugate

agarose conjugate

antibody form

affinity isolated antibody

antibody product type

secondary antibodies

clone

polyclonal

form

PBS suspension

species reactivity

human

should not react with

rat, mouse

capacity

3-4 mg/mL binding capacity (human IgA)

storage temp.

2-8°C

target post-translational modification

unmodified

Quality Level

Application

山羊抗人IgA(α-链特异性)-琼脂糖抗体可用于亲和色谱和定量酶联免疫吸附测定(ELISA)。
用连接琼脂糖的抗人 IgA 抗体进行亲和层析,从 2E9IgA1 转染细胞中纯化蛋白。

Disclaimer

除非我们的目录或随附于产品的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

General description

IgA抗体在粘膜免疫中起着至关重要的作用。它可以结合免疫原/病原体以限制其进入粘膜。抗人IgA(α-链特异性)产品可提高对人IgA的敏感性,而不会与其他物质发生交叉反应。由于与小鼠或大鼠的物种间交叉反应极低,使其适用于筛选由包含小鼠或大鼠免疫球蛋白的杂交瘤细胞产生的抗体。
结合能力:1 mL抗体可结合3-4 mg人IgA。 洗脱能力为2-4 mg/mL。

Immunogen

人艾巴氏病毒转化细胞系产生的 IgA。

Physical form

0.01 M 磷酸盐缓冲盐水(pH 7.4)混悬液,含 15 mM 叠氮化钠

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Poor ex vivo induction of T-cell responses to idiotype or tumor cell lysate-pulsed autologous dendritic cells in advanced pre-treated multiple myeloma
Garderet L, et al.
Leukemia & Lymphoma, 47(7), 1340-1347 (2006)
Yuanyi Yue et al.
Frontiers in immunology, 12, 758040-758040 (2022-02-11)
The tumor microenvironment (TME) plays an important role in the pathogenesis of many cancers. We aimed to screen the TME-related hub genes of colorectal adenoma (CRAD) and identify possible prognostic biomarkers. The gene expression profiles and clinical data of 464
Florian Erger et al.
Proceedings of the National Academy of Sciences of the United States of America, 120(22), e2211087120-e2211087120 (2023-05-22)
Mutations in genes encoding molecular chaperones can lead to chaperonopathies, but none have so far been identified causing congenital disorders of glycosylation. Here we identified two maternal half-brothers with a novel chaperonopathy, causing impaired protein O-glycosylation. The patients have a
M Kristen Demoruelle et al.
Arthritis research & therapy, 23(1), 163-163 (2021-06-08)
Mucosal sites are hypothesized to play a role in the development of rheumatoid arthritis (RA). Since serum anti-peptidylarginine deiminase (PAD)4 antibodies, including a subset that cross-react with PAD3 (PAD3/4), are specific for RA and associate with severe disease, we sought
Yasuyuki Matsumoto et al.
Science advances, 8(43), eabm8783-eabm8783 (2022-10-29)
The underlying pathology of immunoglobulin A (IgA) nephropathy (IgAN), the most common glomerulonephritis worldwide, is driven by the deposition of immune complexes containing galactose-deficient IgA1 [Tn(+)IgA1] in the glomerular mesangium. Here, we report that novel anti-Tn circulating immune complexes (anti-Tn

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持